JAMA Neurology

JAMA Neurology (ISSN 2168-6149) is a premier international journal in the field of neurology, published monthly by the American Medical Association in Chicago, United States. As a leading publication within the medical sciences, it maintains a high impact factor of 29.0 (2022) and is consistently ranked in the top tier (Zone 1) of the Chinese Academy of Sciences journal rankings for both general medicine and neurology, reflecting its prestigious standing in the global academic community. The journal is indexed in SCI and is renowned for its rigorous peer-review process and high academic standards, accepting only high-quality original research, reviews, and commentaries that demonstrate significant clinical and scientific value. Its scope encompasses a broad spectrum of neurological disciplines, including cerebrovascular diseases, neurodegenerative disorders, epilepsy, multiple sclerosis, neuroimmunology, neurogenetics, and neuroimaging. Although the journal operates on a non-open-access model, requiring readers to pay for full-text access, it remains a highly competitive venue for researchers seeking to disseminate innovative findings with substantial clinical implications, attracting a dedicated audience of neurologists, researchers, and healthcare professionals worldwide.